Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313857047> ?p ?o ?g. }
- W4313857047 abstract "Chondrosarcomas are primary cancers of cartilaginous tissue and capable of alteration to highly aggressive, metastatic, and treatment-refractory states, leading to a poor prognosis with a five-year survival rate at 11 months for dedifferentiated subtype. At present, the surgical resection of chondrosarcoma is the only effective treatment, and no other treatment options including targeted therapies, conventional chemotherapies, or immunotherapies are available for these patients. Here, we identify a signal pathway way involving EZH2/SULF1/cMET axis that contributes to malignancy of chondrosarcoma and provides a potential therapeutic option for the disease. A non-biased chromatin immunoprecipitation sequence, cDNA microarray analysis, and validation of chondrosarcoma cell lines identified sulfatase 1 (SULF1) as the top EZH2-targeted gene to regulate chondrosarcoma progression. Overexpressed EZH2 resulted in downregulation of SULF1 in chondrosarcoma cell lines, which in turn activated cMET pathway. Pharmaceutical inhibition of cMET or genetically silenced cMET pathway significantly retards the chondrosarcoma growth and extends mice survival. The regulation of EZH2/SULF1/cMET axis were further validated in patient samples with chondrosarcoma. The results not only established a signal pathway promoting malignancy of chondrosarcoma but also provided a therapeutic potential for further development of effective target therapy to treat chondrosarcoma." @default.
- W4313857047 created "2023-01-10" @default.
- W4313857047 creator A5018769898 @default.
- W4313857047 creator A5022548337 @default.
- W4313857047 creator A5024009281 @default.
- W4313857047 creator A5038564936 @default.
- W4313857047 creator A5040592037 @default.
- W4313857047 creator A5048837073 @default.
- W4313857047 creator A5058942718 @default.
- W4313857047 creator A5068248638 @default.
- W4313857047 creator A5076834432 @default.
- W4313857047 creator A5085335446 @default.
- W4313857047 creator A5089146739 @default.
- W4313857047 creator A5090300999 @default.
- W4313857047 date "2023-01-09" @default.
- W4313857047 modified "2023-10-14" @default.
- W4313857047 title "EZH2/hSULF1 axis mediates receptor tyrosine kinase signaling to shape cartilage tumor progression" @default.
- W4313857047 cites W1176093231 @default.
- W4313857047 cites W178076622 @default.
- W4313857047 cites W1934866169 @default.
- W4313857047 cites W1956818442 @default.
- W4313857047 cites W1963497189 @default.
- W4313857047 cites W1964756237 @default.
- W4313857047 cites W1973195150 @default.
- W4313857047 cites W1978260566 @default.
- W4313857047 cites W1978316906 @default.
- W4313857047 cites W1983545974 @default.
- W4313857047 cites W1986838406 @default.
- W4313857047 cites W1987806206 @default.
- W4313857047 cites W1995652309 @default.
- W4313857047 cites W1998971866 @default.
- W4313857047 cites W2003426260 @default.
- W4313857047 cites W2004639015 @default.
- W4313857047 cites W2004846981 @default.
- W4313857047 cites W2004935845 @default.
- W4313857047 cites W2011376261 @default.
- W4313857047 cites W2011721336 @default.
- W4313857047 cites W2015132841 @default.
- W4313857047 cites W2015177498 @default.
- W4313857047 cites W2016146051 @default.
- W4313857047 cites W2017071197 @default.
- W4313857047 cites W2018237098 @default.
- W4313857047 cites W2026046265 @default.
- W4313857047 cites W2052609775 @default.
- W4313857047 cites W2059058989 @default.
- W4313857047 cites W2066847170 @default.
- W4313857047 cites W2069329627 @default.
- W4313857047 cites W2072658176 @default.
- W4313857047 cites W2074523891 @default.
- W4313857047 cites W2078325464 @default.
- W4313857047 cites W2078468203 @default.
- W4313857047 cites W2085178889 @default.
- W4313857047 cites W2085432002 @default.
- W4313857047 cites W2085932408 @default.
- W4313857047 cites W2108326699 @default.
- W4313857047 cites W2111842868 @default.
- W4313857047 cites W2112992566 @default.
- W4313857047 cites W2132641218 @default.
- W4313857047 cites W2140146894 @default.
- W4313857047 cites W2150312029 @default.
- W4313857047 cites W2152274262 @default.
- W4313857047 cites W2165894156 @default.
- W4313857047 cites W2167749260 @default.
- W4313857047 cites W2171439874 @default.
- W4313857047 cites W2209736027 @default.
- W4313857047 cites W2270704840 @default.
- W4313857047 cites W2330352577 @default.
- W4313857047 cites W2479284487 @default.
- W4313857047 cites W2574440519 @default.
- W4313857047 cites W2782584508 @default.
- W4313857047 cites W2785262117 @default.
- W4313857047 cites W2788603723 @default.
- W4313857047 cites W2885605302 @default.
- W4313857047 cites W2888063998 @default.
- W4313857047 cites W2908283236 @default.
- W4313857047 cites W2914108153 @default.
- W4313857047 cites W2964617822 @default.
- W4313857047 cites W2979372977 @default.
- W4313857047 cites W2984179939 @default.
- W4313857047 cites W3012614768 @default.
- W4313857047 cites W3012891911 @default.
- W4313857047 cites W3023860975 @default.
- W4313857047 cites W3042415932 @default.
- W4313857047 cites W3092064529 @default.
- W4313857047 cites W3117691224 @default.
- W4313857047 cites W4213416504 @default.
- W4313857047 cites W4232129205 @default.
- W4313857047 cites W4313857047 @default.
- W4313857047 doi "https://doi.org/10.7554/elife.79432" @default.
- W4313857047 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36622753" @default.
- W4313857047 hasPublicationYear "2023" @default.
- W4313857047 type Work @default.
- W4313857047 citedByCount "3" @default.
- W4313857047 countsByYear W43138570472023 @default.
- W4313857047 crossrefType "journal-article" @default.
- W4313857047 hasAuthorship W4313857047A5018769898 @default.
- W4313857047 hasAuthorship W4313857047A5022548337 @default.
- W4313857047 hasAuthorship W4313857047A5024009281 @default.
- W4313857047 hasAuthorship W4313857047A5038564936 @default.
- W4313857047 hasAuthorship W4313857047A5040592037 @default.